|
|
|
Outsourcing in Clinical Trials WESTCOAST, Virtual Conference |
 |
|
24-25 February 2021
VIRTUAL CONFERENCE
The two-day Virtual 13th Annual Outsourcing of Clinical Trials West Coast 2021 Conference on February 24-25 convenes at a historic moment for the industry.
This event, primarily for trial sponsors and clinical trial providers, will assess what the industry has learned from the rapid rollout of vaccines and how small to mid-sized pharmaceutical and biotech companies can apply these solutions and tools to trial timelines and costs in the years ahead.
This event includes featured sponsors Medidata, Novotech and Saama Technologies. The 2021 programme has four dedicated streams:
• Clinical Operations & Outsourcing
• Technology & Innovation
• Patient Engagement
• Medical Device Trials
Attendees on Day 1 will hear talks from Ravi Kiron, Head of EMD Serono, who will discuss how to gain investment during a crisis, as well as a technology keynote from Daniel Ramirez at LEO Pharma on the virtualisation of trials. Donald J Kellerman from Zosano Pharma will discuss how Covid-19 will affect the way we outsource and conduct clinical trials in the future.
Day two addresses how to effectively run medical device trials at a local and global level- especially given Covid-19’s disruption to the market this year for small and mid-sized trial sponsors, with key notes and sessions on relevant regulations, digital technology, innovation and Covid-19 responses- ideal for West Coast medical device and life sciences professionals.
Reg. link: https://www.eventsonlineregister.com/tc-events/outsourcing-in-clinical-trials-west-coast-2021-a-virtual-conference/
|
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
MedTech Integrates 2021
22 June 2021, VIRTUAL CONFERENCE
Inspired by the success of the inaugural MedTech Integrates in last
October, Life Science Integrates is delighted to announce the second
Medtech Integrates conference. This one-day gathering of technology,
diagnostics, devices and therapeutics organisations, as well as
clinicians and regulators, provides a platform to discuss the major
challenges impacting the MedTech sector.
More info >> |
|
 |
White Papers |
 |
|
Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences
CIDP (Centre International de Développement Pharmaceutique)
Mauritius, the tropical island situated in the Indian Ocean and known
worldwide for its beautiful beaches, is also internationally recognised
for its rule of law, and political and social stability. Over the past
few years, the economy has been successfully transitioned from a
monocrop to a diversified innovation-driven and knowledge-based economy,
resting on agribusiness, export-oriented manufacturing, tourism,
financial services, property development and real estate, ICT-BPO, the
seafood industry, a free port, logistics and a nascent ocean economy.
Emerging sectors such as healthcare and life sciences are presenting
some niche areas for the taking, and the enabling environment is being
put in place to make it happen - especially in the light of sustained
growth within pharmaceutical, medical device, and clinical research.
Important
international players are already in operation locally as the country
has established the appropriate legal and regulatory frameworks based on
international norms, for the development of a strong biomedical
research sector.
More info >> |
|
 |
News and Press Releases |
 |
OSE Immunotherapeutics and Veloxis Pharmaceuticals Enter Into Global License Agreement to Develop, Manufacture, and Commercialize FR104, a CD28 Antagonist, in the Organ Transplantation Market
Nantes, France – Cary, NC, United States, April 26, 2021 – 6:00PM CET – OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) and Veloxis
Pharmaceuticals Inc., a subsidiary of Asahi Kasei, today announced a
global license agreement granting Veloxis Pharmaceuticals worldwide
rights to develop, manufacture and commercialize FR104.
More info >> |
|
|
